<?xml version="1.0"?>
<Articles JournalTitle="Journal of Medical Bacteriology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Medical Bacteriology</JournalTitle>
      <Issn>2251-8649</Issn>
      <Volume>2</Volume>
      <Issue>1-2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>12</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Distribution of Class I Integron among Isolates of Acinetobacter baumannii Recoverd from Burn Patients</title>
    <FirstPage>1</FirstPage>
    <LastPage>11</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Abdolaziz</FirstName>
        <LastName>Rastegar-Lari</LastName>
        <affiliation locale="en_US">Antimicrobial Resistant Research Center, Tehran University of Medical Sciences, Tehran, IR Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hajar</FirstName>
        <LastName>Mohammadi-Barzelighi</LastName>
        <affiliation locale="en_US">Antimicrobial Resistant Research Center, Tehran University of Medical Sciences, Tehran, IR Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Arjomandzadegan</LastName>
        <affiliation locale="en_US">Tuberculosis and Pediatric Infectious Research Center, Arak University of Medical Sciences, Arak, IR&#xD;
Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Rahim</FirstName>
        <LastName>Nosrati</LastName>
        <affiliation locale="en_US">Molecular Microbiology Research Center, Shahed University, Tehran, IR Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Parviz</FirstName>
        <LastName>Owlia</LastName>
        <affiliation locale="en_US">Molecular Microbiology Research Center, Shahed University, Tehran, IR Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>12</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Acinetobacter baumannii, is an important opportunistic pathogens&#xA0; &#xA0;responsible&#xA0; &#xA0;for&#xA0; &#xA0;nosocomial&#xA0; &#xA0;infections.&#xA0; &#xA0;The&#xA0; &#xA0;aim&#xA0;&#xA0; of&#xA0; &#xA0;this experiment &#xA0;was &#xA0;to &#xA0;determine &#xA0;prevalence &#xA0;of&#xA0; Class &#xA0;I&#xA0; Integron &#xA0;in &#xA0;A. baumannii strains isolated from burn patients in Mottahari Hospital and the drug susceptibility pattern.
Methods: There were 69 Acinetobacter isolates, 68 (98.5%) were identified as A. baumannii. Antimicrobial susceptibility of these isolates were determined by a disk diffusion method. PCR assay for detection of blaOXA-51 like gene (for identity confirmation) and intI was performed.
Results: &#xA0;The &#xA0;most &#xA0;effective &#xA0;antibiotic &#xA0;for &#xA0;treating &#xA0;A. &#xA0;baumannii &#xA0;was colistin, followed by tetracyclin and tobramycin. The presence of Integron class &#xA0;I &#xA0;was &#xA0;detected &#xA0;in &#xA0;14.49% &#xA0;of &#xA0;isolates. &#xA0;ESBL &#xA0;and &#xA0;carbapenemase production were observed in 10% and 24.6% of isolates, respectively.
 Conclusion: Due to the high resistance of strains lacking Integron I, the findings are although class I integrons are disseminated among clinical isolates &#xA0;of &#xA0;A. &#xA0;baumannii, &#xA0;at &#xA0;present &#xA0;research, &#xA0;they &#xA0;they &#xA0;do &#xA0;not &#xA0;play important role in dissemination of antibiotic resistance genes in Mottahari Hospital in Tehran, Iran.</abstract>
    <web_url>https://jmb.tums.ac.ir/index.php/jmb/article/view/30</web_url>
    <pdf_url>https://jmb.tums.ac.ir/index.php/jmb/article/download/30/25</pdf_url>
  </Article>
</Articles>
